American Shared Hospital Services (AMS) Q4 2024 earnings summary

Executive summary

• Fiscal Year 2024 revenue grew 32.9% year-over-year to $28.34 million, driven by strategic acquisitions, expansion of direct patient services, and international business development.

• Direct patient services revenue surged 253.4% year-over-year, reflecting the shift toward direct care and new facility openings.

• Leadership transition: Gary Delanois appointed CEO, with Ray Stachowiak remaining as Executive Chairman.

• Net income attributable to shareholders increased 258.4% to $2.2 million, or $0.34 per diluted share, mainly due to a bargain purchase gain and operational improvements.

• Adjusted EBITDA for 2024 was $8.9 million, up 8.9% year-over-year, highlighting improved operational performance.

Financial highlights

• Q4 2024 revenue increased 59.2% year-over-year to $9.07 million, with direct patient services up 420.2%.

• Q4 adjusted EBITDA increased 29% to $3.5 million; however, Q4 net loss was $1.31 million due to $2.9 million in reserves for impaired assets and removal costs.

• FY 2024 gross margin was $9.19 million, slightly down from $9.34 million in FY 2023 due to higher costs in direct patient services.

• Cash and equivalents at year-end were $11.28 million; shareholders' equity was $25.18 million, or $3.92 per share.

• Net income margin for FY 2024 was 7.7%; adjusted EBITDA margin was 31.4%.

Outlook and guidance

• Management expects continued growth from international centers in Mexico, Peru, and Ecuador, and further expansion in Rhode Island.

• Expects increased treatment volumes and physician engagement as staffing at new centers is completed.

• Focus remains on operational efficiencies, technology investment, and expanding health system partnerships for sustained profitability.

• Confident in long-term revenue and profitability growth, supported by a robust business development pipeline.